Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Limited role of N-terminal phosphoserine residues in the activation of transcription by p53

Oncogene volume 23, pages 4477–4487 (2004)Cite this article

Abstract

The p53 tumor suppressor is phosphorylated in response to various cellular stress signals, such as DNA damage, leading to its release from MDM2 and consequent stabilization and activation as a transcription factor. In human U2OS cells, treatment with adriamycin causes p53 to be phosphorylated on all six serine residues tested, leading to the dissociation of p53 from MDM2 and transcription of the p21 and mdm2 genes. In contrast, in these cells, IPTG-dependent induction of p14ARF, which sequesters MDM2 away from p53, does not lead to detectable phosphorylation of any of the five N-terminal serine residues tested (6, 9, 15, 20, 37). Only C-terminal serine 392 is phosphorylated. However, the increase of p21 and mdm2 mRNAs was indistinguishable following treatment with adriamycin or induction of p14ARF. By using cDNA arrays to examine global p53-dependent gene expression in response to adriamycin or p14ARF, we found that most genes were regulated similarly by the two treatments. However, a subset of p53-regulated genes whose products have proliferative roles or regulate VEGF activity, newly described here, are repressed by p14ARF much more than by adriamycin. We conclude that the phosphorylation of p53 on N-terminal serine residues is not required for increased transcription of the great majority of p53-responsive genes and that the induction of p53 by p14ARF, with little phosphorylation, leads to substantial repression of genes whose products have roles in proliferation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Agarwal ML, Agarwal A, Taylor WR, Chernova O, Sharma Y and Stark GR . (1998a). Proc. Natl. Acad. Sci. USA, 95, 14775–14780.

  • Agarwal ML, Agarwal A, Taylor WR and Stark GR . (1995). Proc. Natl. Acad. Sci. USA, 92, 8493–8497.

  • Agarwal ML, Ramana CV, Hamilton M, Taylor WR, DePrimo SE, Bean LJ, Agarwal A, Agarwal MK, Wolfman A and Stark GR . (2001). Oncogene, 20, 2527–2536.

  • Agarwal ML, Taylor WR, Chernov MV, Chernova OB and Stark GR . (1998b). J. Biol. Chem., 273, 1–4.

  • Alarcon R, Koumenis C, Geyer RK, Maki CG and Giaccia AJ . (1999). Cancer Res., 59, 6046–6051.

  • Alarcon-Vargas D and Ronai Z . (2002). Carcinogenesis, 23, 541–547.

  • Appella E and Anderson CW . (2001). Eur. J. Biochem., 268, 2764–2772.

  • Ashcroft M, Taya Y and Vousden KH . (2000). Mol. Cell. Biol., 20, 3224–3233.

  • Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL and Vousden KH . (1998). Nature, 395, 124–125.

  • Bean LJ and Stark GR . (2001). Oncogene, 20, 1076–1084.

  • Bean LJ and Stark GR . (2002). J. Biol. Chem., 277, 1864–1871.

  • Bottger V, Bottger A, Garcia-Echeverria C, Ramos YF, van der Eb AJ, Jochemsen AG and Lane DP . (1999). Oncogene, 18, 189–199.

  • Boyd SD, Tsai KY and Jacks T . (2000). Nat. Cell Biol., 2, 563–568.

  • Chehab NH, Malikzay A, Appel M and Halazonetis TD . (2000). Genes Dev., 14, 278–288.

  • Chernov MV, Bean LJ, Lerner N and Stark GR . (2001). J. Biol. Chem., 276, 31819–31824.

  • Chernova OB, Chernov MV, Ishizaka Y, Agarwal ML and Stark GR . (1998). Mol. Cell. Biol., 18, 536–545.

  • Cong F, Zou X, Hinrichs K, Calame K and Goff SP . (1999). Oncogene, 18, 7731–7739.

  • de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ and Lowe SW . (1998). Genes Dev., 12, 2434–2442.

  • el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B . (1993). Cell, 75, 817–825.

  • Espinosa JM and Emerson BM . (2001). Mol. Cell, 8, 57–69.

  • Fang S, Jensen JP, Ludwig RL, Vousden KH and Weissman AM . (2000). J. Biol. Chem., 275, 8945–8951.

  • Foster CJ and Lozano G . (2002). Oncogene, 21, 3525–3531.

  • Geyer RK, Yu ZK and Maki CG . (2000). Nat. Cell Biol., 2, 569–573.

  • Gottifredi V, Shieh S, Taya Y and Prives C . (2001). Proc. Natl. Acad. Sci. USA, 98, 1036–1041.

  • Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ . (1993). Cell, 75, 805–816.

  • Haupt Y, Maya R, Kazaz A and Oren M . (1997). Nature, 387, 296–299.

  • Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW and Vogelstein B . (1997). Mol. Cell, 1, 3–11.

  • Honda R, Tanaka H and Yasuda H . (1997). FEBS Lett., 420, 25–27.

  • Honda R and Yasuda H . (1999). EMBO J., 18, 22–27.

  • Innocente SA, Abrahamson JL, Cogswell JP and Lee JM . (1999). Proc. Natl. Acad. Sci. USA, 96, 2147–2152.

  • Inoki I, Shiomi T, Hashimoto G, Enomoto H, Nakamura H, Makino K, Ikeda E, Takata S, Kobayashi K and Okada Y . (2002). FASEB J., 16, 219–221.

  • Jing C, Beesley C, Foster CS, Chen H, Rudland PS, West DC, Fujii H, Smith PH and Ke Y . (2001). Cancer Res., 61, 4357–4364.

  • Jing C, Beesley C, Foster CS, Rudland PS, Fujii H, Ono T, Chen H, Smith PH and Ke Y . (2000). Cancer Res., 60, 2390–2398.

  • Jones SN, Roe AE, Donehower LA and Bradley A . (1995). Nature, 378, 206–208.

  • Kaelin Jr WG . (1999). BioEssays, 21, 950–958.

  • Kaeser MD and Iggo RD . (2002). Proc. Natl. Acad. Sci. USA, 99, 95–100.

  • Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF and Sherr CJ . (1998). Proc. Natl. Acad. Sci. USA, 95, 8292–8297.

  • Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G and Sherr CJ . (1997). Cell, 91, 649–659.

  • Kar S, Sakaguchi K, Shimohigashi Y, Samaddar S, Banerjee R, Basu G, Swaminathan V, Kundu TK and Roy S . (2002). J. Biol. Chem., 277, 15579–15585.

  • Kobuke K, Furukawa Y, Sugai M, Tanigaki K, Ohashi N, Matsumori A, Sasayama S, Honjo T and Tashiro K . (2001). J. Biol. Chem., 276, 34105–34114.

  • Komarova EA, Diatchenko L, Rokhlin OW, Hill JE, Wang ZJ, Krivokrysenko VI, Feinstein E and Gudkov AV . (1998). Oncogene, 17, 1089–1096.

  • Koumenis C, Alarcon R, Hammond E, Sutphin P, Hoffman W, Murphy M, Derr J, Taya Y, Lowe SW, Kastan M and Giaccia A . (2001). Mol. Cell. Biol., 21, 1297–1310.

  • Kubbutat MH, Jones SN and Vousden KH . (1997). Nature, 387, 299–303.

  • Lambert PF, Kashanchi F, Radonovich MF, Shiekhattar R and Brady JN . (1998). J. Biol. Chem., 273, 33048–33053.

  • Linke SP, Clarkin KC, Di Leonardo A, Tsou A and Wahl GM . (1996). Genes Dev., 10, 934–947.

  • Ljungman M . (2000). Neoplasia, 2, 208–225.

  • Lowe SW . (1999). Endocr. Relat. Cancer, 6, 45–48.

  • Lundgren K, Montes de Oca Luna R, McNeill YB, Emerick EP, Spencer B, Barfield CR, Lozano G, Rosenberg MP and Finlay CA . (1997). Genes Dev., 11, 714–725.

  • Mayo LD, Turchi JJ and Berberich SJ . (1997). Cancer Res., 57, 5013–5016.

  • McKeller RN, Fowler JL, Cunningham JJ, Warner N, Smeyne RJ, Zindy F and Skapek SX . (2002). Proc. Natl. Acad. Sci. USA, 99, 3848–3853.

  • Midgley CA, Desterro JM, Saville MK, Howard S, Sparks A, Hay RT and Lane DP . (2000). Oncogene, 19, 2312–2323.

  • Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P and Moll UM . (2003). Mol. Cell, 11, 577–590.

  • Momand J, Zambetti GP, Olson DC, George D and Levine AJ . (1992). Cell, 69, 1237–1245.

  • Montes de Oca Luna R, Wagner DS and Lozano G . (1995). Nature, 378, 203–206.

  • Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein B . (1993). Nature, 362, 857–860.

  • Ossovskaya VS, Mazo IA, Chernov MV, Chernova OB, Strezoska Z, Kondratov R, Stark GR, Chumakov PM and Gudkov AV . (1996). Proc. Natl. Acad. Sci. USA, 93, 10309–10314.

  • Palmero I, Pantoja C and Serrano M . (1998). Nature, 395, 125–126.

  • Perry ME, Piette J, Zawadzki JA, Harvey D and Levine AJ . (1993). Proc. Natl. Acad. Sci. USA, 90, 11623–11627.

  • Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C and DePinho RA . (1998). Cell, 92, 713–723.

  • Quelle DE, Zindy F, Ashmun RA and Sherr CJ . (1995). Cell, 83, 993–1000.

  • Reinke V and Lozano G . (1997). Radiat. Res., 148, 115–122.

  • Rizos H, Diefenbach E, Badhwar P, Woodruff S, Becker TM, Rooney RJ and Kefford RF . (2003). J. Biol. Chem., 278, 4981–4989.

  • Rocha S, Campbell KJ and Perkins ND . (2003). Mol. Cell., 12, 15–25.

  • Sakaguchi K, Saito S, Higashimoto Y, Roy S, Anderson CW and Appella E . (2000). J. Biol. Chem., 275, 9278–9283.

  • Saucedo LJ, Carstens BP, Seavey SE, Albee LD2 and Perry ME . (1998). Cell Growth Differ., 9, 119–130.

  • Schlaak JF, Hilkens CM, Costa-Pereira AP, Strobl B, Aberger F, Frischauf AM and Kerr IM . (2002). J. Biol. Chem., 277, 49428–49437.

  • Sherr CJ . (2000). Cancer Res., 60, 3689–3695.

  • Shieh SY, Ahn J, Tamai K, Taya Y and Prives C . (2000). Genes Dev., 14, 289–300.

  • Shieh SY, Ikeda M, Taya Y and Prives C . (1997). Cell, 91, 325–334.

  • Shieh SY, Taya Y and Prives C . (1999). EMBO J., 18, 1815–1823.

  • Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH and Peters G . (1998). EMBO J., 17, 5001–5014.

  • Tao W and Levine AJ . (1999). Proc. Natl. Acad. Sci. USA, 96, 6937–6941.

  • Taylor WR, DePrimo SE, Agarwal A, Agarwal ML, Schonthal AH, Katula KS and Stark GR . (1999). Mol. Biol. Cell, 10, 3607–3622.

  • Taylor WR and Stark GR . (2001). Oncogene, 20, 1803–1815.

  • Vogelstein B, Lane D and Levine AJ . (2000). Nature, 408, 307–310.

  • Weber HO, Samuel T, Rauch P and Funk JO . (2002). Oncogene, 21, 3207–3212.

  • Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF, Sherr CJ and Zambetti GP . (2000). Genes Dev., 14, 2358–2365.

  • Weber JD, Taylor LJ, Roussel MF, Sherr CJ and Bar-Sagi D . (1999). Nat. Cell Biol., 1, 20–26.

  • Wu L and Levine AJ . (1997). Mol. Med., 3, 441–451.

  • Wu X, Bayle JH, Olson D and Levine AJ . (1993). Genes Dev., 7, 1126–1132.

  • Wulf GM, Liou YC, Ryo A, Lee SW and Lu KP . (2002). J. Biol. Chem., 277, 47976–47979.

  • Xiao G, Chicas A, Olivier M, Taya Y, Tyagi S, Kramer FR and Bargonetti J . (2000). Cancer Res., 60, 1711–1719.

  • Zacchi P, Gostissa M, Uchida T, Salvagno C, Avolio F, Volinia S, Ronai Z, Blandino G, Schneider C and Del Sal G . (2002). Nature, 419, 853–857.

  • Zhang Y, Xiong Y and Yarbrough WG . (1998). Cell, 92, 725–734.

  • Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, Tom E, Mack DH and Levine AJ . (2000). Genes Dev., 14, 981–993.

  • Zheng H, You H, Zhou XZ, Murray SA, Uchida T, Wulf G, Gu L, Tang X, Lu KP and Xiao ZX . (2002). Nature, 419, 849–853.

  • Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ and Roussel MF . (1998). Genes Dev., 12, 2424–2433.

Download references

Acknowledgements

We thank Gordon Peters (Cancer Research UK) for the NARF2 cells and members of the Stark and Gudkov labs for helpful discussions. This work was supported by an NRSA postdoctoral followship to MWJ and grants GM 049345 (GRS) and CA 89279 (BRGW) from the National Institutes of Health.

Author information

Authors and Affiliations

  1. Department of Molecular Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, 44195, OH, USA

    Mark W Jackson, Mukesh K Agarwal, Munna L Agarwal, Archana Agarwal & George R Stark

  2. Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, 44195, OH, USA

    Patricia Stanhope-Baker & Bryan RG Williams

Authors
  1. Mark W Jackson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mukesh K Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Munna L Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Archana Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Patricia Stanhope-Baker
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bryan RG Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. George R Stark
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to George R Stark.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jackson, M., Agarwal, M., Agarwal, M. et al. Limited role of N-terminal phosphoserine residues in the activation of transcription by p53. Oncogene 23, 4477–4487 (2004). https://doi.org/10.1038/sj.onc.1207575

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207575

Keywords

This article is cited by

Search

Advanced search

Quick links